Huntington National Bank Corcept Therapeutics Inc Transaction History

Huntington National Bank

  • $13.5 Billion
  • Q3 2024

A detailed history of Huntington National Bank transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Huntington National Bank holds 29 shares of CORT stock, worth $1,626. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29
Previous 29 -0.0%
Holding current value
$1,626
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$22.21 - $34.48 $399 - $620
18 Added 163.64%
29 $0
Q1 2024

May 03, 2024
SELL
$21.1 - $27.46 $1,139 - $1,482
-54 Reduced 83.08%
11 $0
Q4 2023

Feb 07, 2024
SELL
$24.82 - $32.88 $347 - $460
-14 Reduced 17.72%
65 $2,000
Q3 2023

Nov 08, 2023
BUY
$21.97 - $33.8 $1,713 - $2,636
78 Added 7800.0%
79 $2,000
Q4 2021

Jan 21, 2022
BUY
$17.1 - $23.34 $17 - $23
1 New
1 $0
Q2 2020

Jul 30, 2020
SELL
$11.0 - $18.26 $5,819 - $9,659
-529 Closed
0 $0
Q1 2020

Apr 27, 2020
BUY
$10.11 - $14.04 $5,348 - $7,427
529 New
529 $6,000
Q1 2019

Apr 09, 2019
SELL
$10.03 - $15.71 $20,772 - $32,535
-2,071 Closed
0 $0
Q4 2018

Jan 28, 2019
SELL
$11.29 - $17.19 $1,535 - $2,337
-136 Reduced 6.16%
2,071 $28,000
Q3 2018

Oct 18, 2018
SELL
$12.27 - $15.65 $2,134 - $2,723
-174 Reduced 7.31%
2,207 $31,000
Q2 2018

Jul 19, 2018
BUY
$15.3 - $19.69 $6,395 - $8,230
418 Added 21.29%
2,381 $37,000
Q1 2018

Apr 30, 2018
BUY
$14.59 - $25.5 $28,640 - $50,056
1,963 New
1,963 $32,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email